Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
Well help you understand how these two peptides work and the science behind them
Youre not washing your hair with this stuff youre applying it to specific areas where its needed
Injectable peptides are the standard option because they have greater bioavailability and efficacy than oral treatments
Treatment effects estimated by LOCF-based analyses Historically, participants in weight management trials who discontinued their allocated treatment were often censored from the trial, resulting in no or few post-discontinuation weight assessments available for the statistical analysis [24]